Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
With new upgraded suites, Minaris provides a complete offering from GMP cell banking to integrated characterization testing supporting clinical and commercial programs PHILADELPHIA, June 18, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results